Remeven Cream, (50% Urea in a Cream Base)
Recall D-1464-2016, part of FDA recall event 74519. See Stratus Pharmaceuticals's company page.
Stratus Pharmaceuticals Inc started this Class III drug recall on May 26, 2016 (voluntary: firm initiated); FDA lists it as completed.
- Classification: Class III
- Started: May 26, 2016
- Status: Completed
Crystallization; Complaints that cream appears to have crystallized
- Product
- Remeven Cream, (50% Urea in a Cream Base), a) 5.0 oz (142 g) and b) 9.0 oz (255 g) tubes, Rx only, Manufactured by Sonar Products Inc, Carlstadt, NJ. Distributed by Stratus Pharmaceuticals Inc., Miami, FL.
- Quantity
- a) 12,345 tubes; b) 8,578 tubes
- Lots and codes
- a) Lot (Exp): 8020 (02/17), 8096 (07/18), 8125 (08/18), 8169 (10/18). NDC 58980-680-50 b) Lot (Exp): 8020 (02/17), 8125 (08/18), 8170 (10/18). NDC 58980-680-90
- Distribution
- Nationwide and PR
- Recalling firm
- Stratus Pharmaceuticals Inc, Miami, FL, United States
- How the firm notified
- Letter
- FDA classified
- Aug 23, 2016
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports